Author

Atsushi Hayashi

Miyarisan Pharmaceutical Co., Ltd. (Japan)ORCID 0000-0003-4060-2383Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Click to filter · or open tag

2025-2025 · peak 1/yr

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrew Kelvin SewellORCID

Mutual co-authors in cluster

1 paper

ImmunologybioRxivPreprintJul 16, 2025

This study shows that the probiotic CBM588 enhances antitumor γδ T-cell responses in lung cancer patients undergoing checkpoint blockade therapy.

DOI 10.1101/2025.07.16.664923